Abstract
Aberrant brain network development represents a putative aetiological component in mental disorders, which typically emerge during childhood and adolescence. Previous studies have identified resting-state functional connectivity (RSFC) patterns reflecting psychopathology, but the generalisability to other samples and politico-cultural contexts has not been established.
We investigated whether a previously identified cross-diagnostic case-control and autism spectrum disorder (ASD)-specific pattern of RSFC (discovery sample; aged 5-21 from New York City, USA; n=1666) could be validated in a Norwegian convenience-based youth sample (validation sample; aged 9-25 from Oslo, Norway; n=531). As a test of generalisability, we investigated if these diagnosis-derived RSFC patterns were sensitive to levels of symptom burden in both samples, based on an independent measure of symptom burden.
Both the cross-diagnostic and ASD-specific RSFC pattern were validated across samples. Connectivity patterns were significantly associated with thematically appropriate symptom dimensions in the discovery sample. In the validation sample, the ASD-specific RSFC pattern showed a weak, inverse relationship with symptoms of conduct problems, hyperactivity, and prosociality, while the cross-diagnostic pattern was not significantly linked to symptoms.
Diagnosis-derived connectivity patterns in a developmental clinical US sample were validated in a convenience sample of Norwegian youth, however, they were not associated with mental health symptoms.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project was funded by research grants from the Research Council of Norway (Grant Nos. L.T.W: 249795, 273345, 300767), the South-Eastern Norway Regional Health Authority (Grant Nos. L.T.W: 2014097, 2015073, 2016083, 2018076, 2019101. D.A: 2019107, 2020086), KG Jebsen Stiftelsen, ERA-Net Cofund through the ERA PerMedproject IMPLEMENT, the Horizon Europe HORIZON-HLTH-2021-STAYHLTH-01 (101057429), and the European Research Council under the European Union s Horizon 2020 research and Innovation program (L.T.W: ERC StG Grant No. 802998).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We hereby confirm that Regional Committee for Medical & Health Research Ethics, Section A, South East Norway, approved the Research Project Brains and minds in transition (BRAINMINT): Parsing the heterogeneous developmental and genetic architecture of risk and resilience in the adolescent brain on the 18th of December 2019. The Project Manager for the study is Lars Tjelta Westlye and the Institution Responsible for Research is the University of Oslo. The approval has been given on the basis that Research Project will be implemented as described in the Research Protocol.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Clarification
Data Availability
The code and data used in the study will be made available upon publication in a public repository (Open Science Framework) (https://osf.io/cdjw4/).
